Acute Myeloid Leukemia Clinical Trial

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Summary

Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Must have been enrolled in the Celgene protocol CC-5013-MDS-003 study.
Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (i.e. next of kin, legal representative) will be obtained prior to collection of data).

Exclusion Criteria:

1. Consent refused for any reason at current or long-term follow up completed in 2007 (long-term follow up: survival data collection completed to obtain further safety information on CC-5013-MDS-003 discontinued subjects from May - October 2007).

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

54

Study ID:

NCT01099267

Recruitment Status:

Completed

Sponsor:

Celgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 15 Locations for this study

See Locations Near You

Mayo Clinic - Scottsdale
Scottsdale Arizona, 85259, United States
Stanford University Cancer Center
Stanford California, 94305, United States
Cancer & Blood Disease Center
Lecanto Florida, 34461, United States
H. Lee Moffitt Cancer Center
Tampa Florida, 33612, United States
Northwest Georgia Oncology Centers, P.C.
Marietta Georgia, 30060, United States
Hematology Oncology Associates of Illinois
Chicago Illinois, 60611, United States
Rush University Medical Center
Chicago Illinois, 60612, United States
University of Chicago
Chicago Illinois, 60637, United States
John Hopkins University Hospital
Baltimore Maryland, 21231, United States
Mayo Clinic - Rochester
Rochester Minnesota, 55905, United States
Memorial Sloan-Kettering Cancer Center
New York New York, 10065, United States
Wake Forest University
Winston-Salem North Carolina, 27157, United States
The Cleveland Clinic Foundation
Cleveland Ohio, 44195, United States
Fred Hutchinson Cancer Research Center
Seattle Washington, 98109, United States
St. Johannes Hospital
Duisburg , D-471, Germany

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

54

Study ID:

NCT01099267

Recruitment Status:

Completed

Sponsor:


Celgene

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider